NEW YORK (GenomeWeb) – Cell detection and liquid biopsy firm RareCyte said today that it has raised $30 million in a private financing round, which it plans to use to advance commercial sales efforts and build new companion diagnostic partnerships.

The investment was led by 5AM Ventures with additional participation from existing investors including Telegraph Hill Partners.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.